{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-22T12:28:14.625602+00:00","published_at":"2026-10-22T04:47:15.090742+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:5:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"seat_on","from_id":"alpha:person:eric-benevich-2","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Eric Benevich","to_label":"aTYR PHARMA INC","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:6:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"seat_on","from_id":"alpha:person:jane-a-gross","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Jane A. Gross","to_label":"aTYR PHARMA INC","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:7:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"seat_on","from_id":"alpha:person:paul-schimmel","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Paul Schimmel","to_label":"aTYR PHARMA INC","valid_from":"2005-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:8:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"seat_on","from_id":"alpha:person:sanjay-s-shukla","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Sanjay S. Shukla","to_label":"aTYR PHARMA INC","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:9:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"seat_on","from_id":"alpha:person:sara-l-zaknoen","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Sara L. Zaknoen","to_label":"aTYR PHARMA INC","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:10:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"seat_on","from_id":"alpha:person:svetlana-lucas","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Steve Lucas","to_label":"aTYR PHARMA INC","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:11:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"seat_on","from_id":"alpha:person:timothy-p-coughlin","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Timothy P. Coughlin","to_label":"aTYR PHARMA INC","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"seat_on","from_id":"alpha:person:eric-benevich","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Eric Benevich","to_label":"aTYR PHARMA INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"committee_of","from_id":"alpha:committee:atyr-pharma-inc:audit","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Audit","to_label":"aTYR PHARMA INC","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992","alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:chairs:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15:committee:atyr-pharma-inc:audit","relationship_type":"chairs","from_id":"alpha:person:svetlana-lucas","to_id":"alpha:committee:atyr-pharma-inc:audit","from_label":"Steve Lucas","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992"]},{"relationship_id":"alpha:relationship:member_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15:committee:atyr-pharma-inc:audit","relationship_type":"member_of","from_id":"alpha:person:eric-benevich","to_id":"alpha:committee:atyr-pharma-inc:audit","from_label":"Eric Benevich","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:10:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"committee_of","from_id":"alpha:committee:atyr-pharma-inc:audit-chair-nominating-and-governance","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Audit · Chair; Nominating and Governance","to_label":"aTYR PHARMA INC","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:member_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:10:committee:atyr-pharma-inc:audit-chair-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:svetlana-lucas","to_id":"alpha:committee:atyr-pharma-inc:audit-chair-nominating-and-governance","from_label":"Steve Lucas","to_label":"Audit · Chair; Nominating and Governance","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:19:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"committee_of","from_id":"alpha:committee:atyr-pharma-inc:compensation","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Compensation","to_label":"aTYR PHARMA INC","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:19","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992"]},{"relationship_id":"alpha:relationship:chairs:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:19:committee:atyr-pharma-inc:compensation","relationship_type":"chairs","from_id":"alpha:person:jane-a-gross","to_id":"alpha:committee:atyr-pharma-inc:compensation","from_label":"Jane A. Gross","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:19","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992"]},{"relationship_id":"alpha:relationship:member_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:19:committee:atyr-pharma-inc:compensation","relationship_type":"member_of","from_id":"alpha:person:eric-benevich","to_id":"alpha:committee:atyr-pharma-inc:compensation","from_label":"Eric Benevich","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:19","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:6:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"committee_of","from_id":"alpha:committee:atyr-pharma-inc:compensation-chair-nominating-and-governance","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Compensation · Chair; Nominating and Governance","to_label":"aTYR PHARMA INC","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:member_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:6:committee:atyr-pharma-inc:compensation-chair-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:jane-a-gross","to_id":"alpha:committee:atyr-pharma-inc:compensation-chair-nominating-and-governance","from_label":"Jane A. Gross","to_label":"Compensation · Chair; Nominating and Governance","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:9:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"committee_of","from_id":"alpha:committee:atyr-pharma-inc:compensation-nominating-and-governance-chair","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Compensation; Nominating and Governance · Chair","to_label":"aTYR PHARMA INC","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:member_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:9:committee:atyr-pharma-inc:compensation-nominating-and-governance-chair","relationship_type":"member_of","from_id":"alpha:person:sara-l-zaknoen","to_id":"alpha:committee:atyr-pharma-inc:compensation-nominating-and-governance-chair","from_label":"Sara L. Zaknoen","to_label":"Compensation; Nominating and Governance · Chair","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:23:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"committee_of","from_id":"alpha:committee:atyr-pharma-inc:nominating-and-governance","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Nominating and Governance","to_label":"aTYR PHARMA INC","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:23","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992"]},{"relationship_id":"alpha:relationship:chairs:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:23:committee:atyr-pharma-inc:nominating-and-governance","relationship_type":"chairs","from_id":"alpha:person:sara-l-zaknoen","to_id":"alpha:committee:atyr-pharma-inc:nominating-and-governance","from_label":"Sara L. Zaknoen","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:23","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992"]},{"relationship_id":"alpha:relationship:member_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:23:committee:atyr-pharma-inc:nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:jane-a-gross","to_id":"alpha:committee:atyr-pharma-inc:nominating-and-governance","from_label":"Jane A. Gross","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:23","evidence_ids":["alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:12:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"executive_of","from_id":"alpha:person:jill-m-broadfoot-atyr","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Jill M. Broadfoot","to_label":"aTYR PHARMA INC","valid_from":"2026-03-26","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:b339c7a87b83316b65065271fc7631856ceea79838a867cef7d9d700327cfb56"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:13:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"executive_of","from_id":"alpha:person:nancy-e-denyes-atyr","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Nancy E. Denyes","to_label":"aTYR PHARMA INC","valid_from":"2026-03-26","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:d3d2cd3b48727f1f75f1e71caa91278ff34702e60bd27d77aeffb9f8c17bbb40"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:14:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","relationship_type":"executive_of","from_id":"alpha:person:sanjay-s-shukla-m-d-m-s-atyr","to_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","from_label":"Sanjay S. Shukla, M.D., M.S.","to_label":"aTYR PHARMA INC","valid_from":"2026-03-26","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:156fb0a061d6a7e3f81b62113d75820c2a6d14698585d5c95063b4760ab33b40"]}]},"claims":[{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:5","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:eric-benevich-2","object_label":"Eric Benevich","object_source_name_forms":[],"value":"Eric Benevich: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:eric-benevich-2","name":"Eric Benevich"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"aTYR PHARMA INC DEF 14A 2026-03-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26","retrieved_at":"2026-04-24T16:03:01.969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:6","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jane-a-gross","object_label":"Jane A. Gross","object_source_name_forms":[],"value":"Jane A. Gross: Director, Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jane-a-gross","name":"Jane A. Gross"},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"aTYR PHARMA INC DEF 14A 2026-03-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26","retrieved_at":"2026-04-24T16:03:01.969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:7","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:paul-schimmel","object_label":"Paul Schimmel","object_source_name_forms":[],"value":"Paul Schimmel: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:paul-schimmel","name":"Paul Schimmel"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2005-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2005-01-01","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"aTYR PHARMA INC DEF 14A 2026-03-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26","retrieved_at":"2026-04-24T16:03:01.969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26","effective_from":"2005-01-01","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:8","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sanjay-s-shukla","object_label":"Sanjay S. Shukla","object_source_name_forms":[],"value":"Sanjay S. Shukla: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sanjay-s-shukla","name":"Sanjay S. Shukla"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"aTYR PHARMA INC DEF 14A 2026-03-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26","retrieved_at":"2026-04-24T16:03:01.969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:9","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sara-l-zaknoen","object_label":"Sara L. Zaknoen","object_source_name_forms":[],"value":"Sara L. Zaknoen: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sara-l-zaknoen","name":"Sara L. Zaknoen"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"aTYR PHARMA INC DEF 14A 2026-03-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26","retrieved_at":"2026-04-24T16:03:01.969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:10","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:svetlana-lucas","object_label":"Steve Lucas","object_source_name_forms":[],"value":"Steve Lucas: Director, Audit · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:svetlana-lucas","name":"Steve Lucas"},"title":"Director","role_category":"director","committee":"Audit · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"aTYR PHARMA INC DEF 14A 2026-03-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26","retrieved_at":"2026-04-24T16:03:01.969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:11","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:timothy-p-coughlin","object_label":"Timothy P. Coughlin","object_source_name_forms":[],"value":"Timothy P. Coughlin: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:timothy-p-coughlin","name":"Timothy P. Coughlin"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"aTYR PHARMA INC DEF 14A 2026-03-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26","retrieved_at":"2026-04-24T16:03:01.969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:12","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jill-m-broadfoot-atyr","object_label":"Jill M. Broadfoot","object_source_name_forms":[],"value":"Jill M. Broadfoot: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jill-m-broadfoot-atyr","name":"Jill M. Broadfoot"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-26","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-26","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:b339c7a87b83316b65065271fc7631856ceea79838a867cef7d9d700327cfb56","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATYR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:18.869642+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26T00:00:00+00:00","effective_from":"2026-03-26","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:13","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:nancy-e-denyes-atyr","object_label":"Nancy E. Denyes","object_source_name_forms":[],"value":"Nancy E. Denyes: General Counsel and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:nancy-e-denyes-atyr","name":"Nancy E. Denyes"},"title":"General Counsel and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-26","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-26","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:d3d2cd3b48727f1f75f1e71caa91278ff34702e60bd27d77aeffb9f8c17bbb40","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATYR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:19.390703+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26T00:00:00+00:00","effective_from":"2026-03-26","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:leadership_role:14","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sanjay-s-shukla-m-d-m-s-atyr","object_label":"Sanjay S. Shukla, M.D., M.S.","object_source_name_forms":[],"value":"Sanjay S. Shukla, M.D., M.S.: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sanjay-s-shukla-m-d-m-s-atyr","name":"Sanjay S. Shukla, M.D., M.S."},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-26","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-26","valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:document:156fb0a061d6a7e3f81b62113d75820c2a6d14698585d5c95063b4760ab33b40","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATYR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:18.307299+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-26T00:00:00+00:00","effective_from":"2026-03-26","effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:15","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Steve Lucas; Members Steve Lucas (Chair); Eric Benevich; Timothy P. Coughlin","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Steve Lucas","members":[{"display_name":"Steve Lucas","person_slug":"svetlana-lucas","is_chair":true},{"display_name":"Eric Benevich","person_slug":"eric-benevich","is_chair":false},{"display_name":"Timothy P. Coughlin","person_slug":"timothy-p-coughlin","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:19","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Jane A. Gross; Members Jane A. Gross (Chair); Eric Benevich; Sara L. Zaknoen","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Jane A. Gross","members":[{"display_name":"Jane A. Gross","person_slug":"jane-a-gross","is_chair":true},{"display_name":"Eric Benevich","person_slug":"eric-benevich","is_chair":false},{"display_name":"Sara L. Zaknoen","person_slug":"sara-l-zaknoen","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52:committee_record:23","subject_id":"alpha:company:5a5d61fb-43a7-4c3d-b3d2-12ffbc7dde52","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Sara L. Zaknoen; Members Sara L. Zaknoen (Chair); Jane A. Gross; Steve Lucas","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Sara L. Zaknoen","members":[{"display_name":"Sara L. Zaknoen","person_slug":"sara-l-zaknoen","is_chair":true},{"display_name":"Jane A. Gross","person_slug":"jane-a-gross","is_chair":false},{"display_name":"Steve Lucas","person_slug":"svetlana-lucas","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-22T04:47:15.090742+00:00","sources":[{"id":"alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:8073b388e47d621917490c30cc503c10331ec7645f4a53419e34a3bb2468c15c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"aTYR PHARMA INC DEF 14A 2026-03-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26","retrieved_at":"2026-04-24T16:03:01.969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b339c7a87b83316b65065271fc7631856ceea79838a867cef7d9d700327cfb56","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATYR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:18.869642+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d3d2cd3b48727f1f75f1e71caa91278ff34702e60bd27d77aeffb9f8c17bbb40","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATYR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:19.390703+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:156fb0a061d6a7e3f81b62113d75820c2a6d14698585d5c95063b4760ab33b40","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATYR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":"2026-03-26T00:00:00+00:00","retrieved_at":"2026-05-14T23:45:18.307299+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:01b1343c8e0e5ae5e79074eaa16b41f067d28995fa2f07a6929e49d736431992","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1339970/000133997026000021/atyr-20260326.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.836,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.9,"cross_source_agreement":0.75,"temporal_completeness":0.526},"diagnostics":{"published_claims":26,"factual_claims":26,"claims_with_linked_evidence":26,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":19,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-22T04:47:15.090742+00:00","observed_at":"2026-10-22T04:47:15.090742+00:00","reviewed_at":"2026-10-22T04:47:15.090742+00:00","verified_at":"2026-10-22T04:47:15.090742+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/atyr-pharma-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/atyr-pharma-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}